Evaluation of the Safety, Tolerability, and Pharmacokinetic Profiles of TP0473292 (TS-161), A Prodrug of a Novel Orthosteric mGlu2/3 Receptor Antagonist TP0178894, in Healthy Subjects and Its Antidepressant-Like Effects in Rodents

BACKGROUND: TP0473292 (the active ingredient of TS-161) is a prodrug of a novel metabotropic glutamate (mGlu) 2/3 receptor antagonist being developed for the treatment of patients with depression. This study evaluated the safety, tolerability, and pharmacokinetics of orally administered TS-161 in he...

Descripción completa

Detalles Bibliográficos
Autores principales: Watanabe, Mai, Marcy, Brian, Hiroki, Ayano, Watase, Hirotaka, Kinoshita, Kohnosuke, Iijima, Michihiko, Marumo, Toshiyuki, Zarate, Carlos A, Chaki, Shigeyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Regular Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8832229/
https://www.ncbi.nlm.nih.gov/pubmed/34534292
http://dx.doi.org/10.1093/ijnp/pyab062

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8832229/
https://www.ncbi.nlm.nih.gov/pubmed/34534292
http://dx.doi.org/10.1093/ijnp/pyab062

Ejemplares similares